Narrative Review: Ketosis-Prone Type 2 Diabetes Mellitus
- 7 March 2006
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 144 (5), 350-357
- https://doi.org/10.7326/0003-4819-144-5-200603070-00011
Abstract
Several investigators have reported that more than half of African-American persons with new diagnoses of diabetic ketoacidosis have clinical, metabolic, and immunologic features of type 2 diabetes during follow-up. These patients are usually obese, have a strong family history of diabetes, have a low prevalence of autoimmune markers, and lack a genetic association with HLA. Their initial presentation is acute, with a few days to weeks of polyuria, polydipsia, and weight loss and lack of a precipitating cause of metabolic decompensation. At presentation, they have markedly impaired insulin secretion and insulin action, but intensified diabetic management results in significant improvement in β-cell function and insulin sensitivity sufficient to allow discontinuation of insulin therapy within a few months of follow-up. On discontinuation of insulin therapy, the period of near-normoglycemic remission may last for a few months to several years. The absence of autoimmune markers and the presence of measurable insulin secretion have proven useful in predicting near-normoglycemic remission and long-term insulin dependence in adult patients with a history of diabetic ketoacidosis. This clinical presentation is commonly reported in African and African-American persons but is also observed in Hispanic persons and those from other minority ethnic groups. The underlying mechanisms for β-cell dysfunction in ketosis-prone type 2 diabetes are not known; however, preliminary evidence suggests an increased susceptibility to glucose desensitization.Keywords
This publication has 38 references indexed in Scilit:
- Metabolic and immunogenetic prediction of long‐term insulin remission in African patients with atypical diabetesDiabetic Medicine, 2002
- The Occurrence of Diabetic Ketoacidosis in Adults.Internal Medicine, 2000
- Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis.Diabetes Care, 1999
- Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDMDiabetes, 1996
- Ketoacidosis-Onset Noninsulin Dependent Diabetes in Japanese SubjectsThe American Journal of the Medical Sciences, 1995
- Scope and Heterogeneous Nature of MODYDiabetes Care, 1990
- Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetesDiabetes, 1987
- Maturity-Onset Diabetes of Youth in Black AmericansNew England Journal of Medicine, 1987
- Epidemiology and Treatment of Diabetic Ketoacidosis in a Community PopulationDiabetes Care, 1984
- Diabetes in the tropics.BMJ, 1967